Literature DB >> 22231230

Vasculitis in 2011: the renaissance of granulomatous inflammation in AAV.

Stephan D Gadola1, Wolfgang L Gross.   

Abstract

In 2011, the year that subtypes of ANCA-associated vasculitis (AAV) were officially renamed according to key pathological characteristics, important progress was made not only in differentiating these subtypes, but also in understanding—and treating—their eponymous manifestations.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22231230     DOI： 10.1038/nrrheum.2011.218

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


  12 in total

1.  Are there specific genetic risk factors for the different forms of ANCA-associated vasculitis?

Authors:  Larissa Arning; Julia Ulrike Holle; Lorraine Harper; David S Millar; Wolfgang Ludwig Gross; Jörg Thomas Epplen; Stefan Wieczorek
Journal:  Ann Rheum Dis       Date:  2010-08-10       Impact factor: 19.103

2.  Images in clinical medicine. Destructive eye lesions in Wegener's granulomatosis.

Authors:  Peer Malte Aries; Marcus Both
Journal:  N Engl J Med       Date:  2005-01-27       Impact factor: 91.245

3.  Molecular signatures of a disturbed nasal barrier function in the primary tissue of Wegener's granulomatosis.

Authors:  M Laudien; R Häsler; J Wohlers; J Böck; S Lipinski; L Bremer; R Podschun; P Ambrosch; P Lamprecht; P Rosenstiel; A Till
Journal:  Mucosal Immunol       Date:  2011-03-16       Impact factor: 7.313

4.  ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process.

Authors:  N J Holden; J M Williams; M D Morgan; A Challa; J Gordon; R J Pepper; A D Salama; L Harper; C O S Savage
Journal:  Ann Rheum Dis       Date:  2011-08-21       Impact factor: 19.103

5.  Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K.

Authors:  Shouichi Fujimoto; Richard A Watts; Shigeto Kobayashi; Kazuo Suzuki; David R W Jayne; David G I Scott; Hiroshi Hashimoto; Hiroyuki Nunoi
Journal:  Rheumatology (Oxford)       Date:  2011-07-28       Impact factor: 7.580

6.  Improved differentiation between Churg-Strauss syndrome and Wegener's granulomatosis by an artificial neural network.

Authors:  W H Schmitt; R Linder; E Reinhold-Keller; W L Gross
Journal:  Arthritis Rheum       Date:  2001-08

7.  Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations.

Authors:  Julia U Holle; Christin Dubrau; Karen Herlyn; Martin Heller; Petra Ambrosch; Bernhard Noelle; Eva Reinhold-Keller; Wolfgang L Gross
Journal:  Ann Rheum Dis       Date:  2011-10-21       Impact factor: 19.103

8.  Differentiation between Wegener's granulomatosis and microscopic polyangiitis by an artificial neural network and by traditional methods.

Authors:  Roland Linder; Isabelle Orth; E Christian Hagen; Fokko J van der Woude; Wilhelm H Schmitt
Journal:  J Rheumatol       Date:  2011-02-15       Impact factor: 4.666

9.  Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?

Authors:  Julia U Holle; Wolfgang L Gross; Konstanze Holl-Ulrich; Petra Ambrosch; Bernhard Noelle; Marcus Both; Elena Csernok; Frank Moosig; Susanne Schinke; Eva Reinhold-Keller
Journal:  Ann Rheum Dis       Date:  2010-05-28       Impact factor: 19.103

10.  Wegener's granuloma harbors B lymphocytes with specificities against a proinflammatory transmembrane protein and a tetraspanin.

Authors:  Lorenz Thurner; Antje Müller; Martine Cérutti; Thierry Martin; Jean-Louis Pasquali; Wolfgang L Gross; Klaus-Dieter Preuss; Michael Pfreundschuh; Jan Voswinkel
Journal:  J Autoimmun       Date:  2010-10-14       Impact factor: 7.094
View more
  10 in total

Review 1.  Endothelium-neutrophil interactions in ANCA-associated diseases.

Authors:  Lise Halbwachs; Philippe Lesavre
Journal:  J Am Soc Nephrol       Date:  2012-09       Impact factor: 10.121

Review 2.  Advances in therapy for ANCA-associated vasculitis.

Authors:  Duvuru Geetha; Philip Seo
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

Review 3.  Granuloma in ANCA-associated vasculitides: another reason to distinguish between syndromes?

Authors:  Antje Mueller; Konstanze Holl-Ulrich; Wolfgang L Gross
Journal:  Curr Rheumatol Rep       Date:  2013-11       Impact factor: 4.592

Review 4.  The Fatal Circle of NETs and NET-Associated DAMPs Contributing to Organ Dysfunction.

Authors:  Helena Block; Jan Rossaint; Alexander Zarbock
Journal:  Cells       Date:  2022-06-14       Impact factor: 7.666

5.  Plasma cells within granulomatous inflammation display signs pointing to autoreactivity and destruction in granulomatosis with polyangiitis. Artiritis Research and Therapy 2014, 16: R55.

Authors:  Tavleen Kaur
Journal:  Ann Neurosci       Date:  2015-01

6.  M2 macrophage is the predominant phenotype in airways inflammatory lesions in patients with granulomatosis with polyangiitis.

Authors:  Alexandre Wagner Silva de Souza; Mirjan van Timmeren; Jan-Stephan Sanders; Coen Stegeman; Peter Heeringa; Cees G M Kallenberg; Johanna Westra
Journal:  Arthritis Res Ther       Date:  2017-05-18       Impact factor: 5.156

Review 7.  The Expanding Role of Extracellular Traps in Inflammation and Autoimmunity: The New Players in Casting Dark Webs.

Authors:  Stephanie U-Shane Huang; Kim Maree O'Sullivan
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

8.  Clinical use of biologics in vasculitis syndromes.

Authors:  Marino Paroli
Journal:  Biologics       Date:  2012-10-25

9.  Plasma cells within granulomatous inflammation display signs pointing to autoreactivity and destruction in granulomatosis with polyangiitis.

Authors:  Antje Mueller; Christoph Brieske; Susanne Schinke; Elena Csernok; Wolfgang L Gross; Katrin Hasselbacher; Jan Voswinkel; Konstanze Holl-Ulrich
Journal:  Arthritis Res Ther       Date:  2014-02-20       Impact factor: 5.156

Review 10.  Neutrophil Extracellular Traps in ANCA-Associated Vasculitis.

Authors:  Daniel Söderberg; Mårten Segelmark
Journal:  Front Immunol       Date:  2016-06-30       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.